Ventripoint Diagnostics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
18 Hook Ave Unit 101, Toronto, Ontario, ...Phone Number
(416) 848-4156Website
www.ventripoint.comRevenue
<$5 MillionStock Symbol
VPTDFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Ventripoint Diagnostics
Ventripoint Diagnostics Ltd. specializes in advanced cardiac imaging solutions utilizing patented AI technology to transform ultrasound scans into high-fidelity 3D models of the heart. Their flagship product, VMS+, serves as a diagnostic aid that offers rapid, accurate assessments of heart structure and function, comparable to traditional MRI but at a significantly lower cost and time. The company aims to provide these innovative tools to major hospitals across Europe, the U.K., the U.S., and Canada, enhancing patient care and diagnostic precision. Ventripoint is committed to improving the standard of heart health diagnostics globally.Explore more
Ventripoint Diagnostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ventripoint Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ventripoint Diagnostics
Funding: Get notified immidiatlly once Ventripoint Diagnostics has new funding data
Product Launch: Get notified when Ventripoint Diagnostics launches new products
Check if Ventripoint Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Check out if Ventripoint Diagnostics is spiking on competitors!
Click to see if Ventripoint Diagnostics had a recent Job posting/layoffs
Ventripoint Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Ventripoint Diagnostics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Ventripoint Diagnostics
Compare insights from companies similar to Ventripoint Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ventripoint Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ventripoint Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ventripoint Diagnostics.
Ventripoint Diagnostics financials insights
Gather financial insights about Ventripoint Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$748K
2024
Other Financing Round
$1.1M
Ventripoint Diagnostics Tech Stack
A closer look at the technologies used by Ventripoint Diagnostics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Product Launch
Ventripoint Diagnostics has introduced a device-as-a-service (DAS) subscription model to reduce friction, shorten the sales cycle, and create a more predictable stream of recurring revenue. By offering subscription-based access, the company aims to make adoption easier for healthcare providers while establishing a stronger base of sustainable revenue.
Product Launch, Business Finance, Finance, Pricing, Revenue Operations
Project
expects to begin seeing sales from its China licensee in the first quarter and is pushing for Chinese FDA approval on the product. The company's understanding is that a number of sales will be permissible prior to approval in tertiary care centers and research centers.
Sales, Governmental Affairs & Regulation, Regulations
Project
Customer Experience, Healthcare Operations
Ventripoint Diagnostics News & Media
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER, BC, March 27, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The traditional hospital model is undergoing a massive structural shift. Outpatient clinics and ambulatory services are quickly becoming the primary growth...How Decentralized AI is Unlocking Value in Cardiac Diagnostics
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER,BC, March 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the European Union over €282 billion annually while...Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript
Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call February 26, 2026 1:00 PM ESTCompany ParticipantsHugh MacNaught - CEO, President &...Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer
(TheNewswire)New CFO appointment strengthensVentripoint’s leadership team and supports global rollout ofAI-powered VMS+™ cardiac imaging platform.Toronto, Ontario – TheNewswire - December 3, 2025 -Ventripoint Diagnostics Ltd. ("Ventripoint",“VPT” or the "Company"), (TSXV:VPT; OTC:VPTDF) a leaderin…
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Ventripoint Diagnostics
Sign Up For FreeTo access detailed company insights
Ventripoint Diagnostics Ltd. specializes in advanced cardiac imaging solutions utilizing patented AI technology to transform ultrasound scans into high-fidelity 3D models of the heart. Their flagship product, VMS+, serves as a diagnostic aid that offers rapid, accurate assessments of heart structure and function, comparable to traditional MRI but a... Read More
